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Abstract
Many applications of stem cell technologies require a large quantity of cells for which scalable 
processes of cell expansion and differentiation are essential. Multipotent adult progenitor cells 
(MAPCs) are adult stem cells isolated from the bone marrow with extensive self-renewal and broad 
differentiation capabilities. MAPCs are typically cultured surface adherent (2D) and at low cell 
density, making the large surface required for cell expansion a hindrance for many applications. This 
study demonstrates that MAPCs can be cultivated as aggregates in an undifferentiated state for at least 
16 days, as levels of a number of transcripts, including Oct4, remained similar, Oct4 protein was 
unchanged, and differentiation to neural progenitor, endothelial cell and hepatocyte like cells was 
retained.  Cultivation of these aggregates in stirred bioreactor lead to a 70-fold expansion in six days 
with final cell densities of close to 10
6
/ml.  Importantly, the MAPC aggregates recovered from stirred 
bioreactors could be differentiated to hepatocyte-like cells that expressed albumin, alpha-1-antitrypsin 
(AAT), and tyrosine amino transferase (TAT) transcripts and also secreted albumin and urea. This 
method of scalable expansion combined with differentiation of MAPCs can potentially be used for 
generating large numbers of MAPC and MAPC-derived differentiated cells.
KEYWORDS: MULTIPOTENT ADULT PROGENITOR CELLS, 3D AGGREGATES, STIRRED SUSPENSION CULTURE
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INTRODUCTION
With the growing potential of stem cells for applications in cellular therapy and drug toxicity 
screening, there is an increasing need for the design of robust bioprocesses for their scalable expansion 
and differentiation. The widespread use and extensive experience with stirred suspension culture 
systems for microbial and mammalian cell culture, makes them an attractive option as a large scale 
culture system for stem cell technologies. Stirred suspension cultures provide a more homogenous
culture environment along with the capability for online monitoring and control of physicochemical
parameters such as nutrient and cytokine concentrations, oxygen and pH. Moreover, cell 
concentrations of 10
6
-10
7
 cells/ml can be attained in conventional suspension bioreactors. High cell 
density culture in the bioreactors and minimal need of manual intervention results in a more cost-
effective bioprocess. Thus, to meet the clinical need of ~10
9
-10
10
 cells per treatment, bioreactors of
working volumes in the range of 100 ml to a few liters are sufficient. Further, as these culture systems
are already commonly used in the conventional cell culture industry, adapting them for use in 
development of stem cell related bioprocesses would be straightforward and thus minimize design 
costs.
Suspension culture has been used in the expansion and differentiation of murine and human embryonic
stem cells (ESC) by cultivating them as aggregates or on microcarriers (Abranches et al. 2007; 
Cameron et al. 2006; Cormier et al. 2006; Dang et al. 2004; Fok and Zandstra 2005; Krawetz et al. 
2009; Lock and Tzanakakis 2009; Oh et al. 2009; zur Nieden et al. 2007). It is also possible to culture 
adult stem cells, such as hematopoietic stem and progenitor cells (Li et al. 2006), neural stem cells 
(Gilbertson et al. 2006) and mesenchymal stem cells (MSCs) (Frauenschuh et al. 2007; Yu et al. 2009) 
in suspension. Most studies involving MSCs have either been with cells seeded on microcarriers
(Frauenschuh et al. 2007) or embedded within 3D polymeric scaffolds (Zhao and Ma 2005). In a recent 
study, the culture of MSCs as multi-cellular three-dimensional (3D) aggregates was demonstrated as 
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another mode for culture in suspension (Frith et al. 2009).  Aside from the obvious advantage of large-
scale cell production in a spinner culture system, there is also increasing evidence of a significantly 
better recapitulation of the in-vivo phenotype and biological response in 3D aggregates than in 
traditional two-dimensional (2D) monolayer culture methods. This is thought to be due to differences 
in cell-cell and cell-matrix interactions, cell shape, spatial gradients, leading to differences in gene and 
protein expression. Thus, the potential applications of these 3D systems also extend to developing 
‘biomemtic’ 3D tissues/organoids and as a in-vitro model for studying differentiation, organogenesis, 
migration, tumor biology, and in high-throughput drug screening (Griffith and Swartz 2006; Keller et 
al. 2006; Liu et al. 2009; Ong et al. 2009; Pampaloni et al. 2007; Yamada and Cukierman 2007).
Multipotent Adult Progenitor Cells (MAPC) (Breyer et al. 2006; Jiang et al. 2002; Reyes et al. 2001) 
are isolated from the bone marrow with extensive proliferation capability and differentiation potential 
into multiple cell types including the endothelial and smooth muscle cells (Luttun et al. 2006), and 
hepatocytes (Schwartz et al. 2002), among others. When isolated from rodent bone marrow (mouse
and rat), we have found that MAPC express high levels of Oct4 at the mRNA and protein level, but do 
not express Nanog or Sox2. However, they also express transcription factors found in primitive
endoderm and the recently described Xen-P cells (Debeb et al. 2009; Galat et al. 2009), such as Sox7,
Sox17, Foxa2, Gata4, and Gata6 (Ulloa-Montoya et al. 2007). 
Since the initial isolation of MAPC, other adult stem cells with similar broader differentiation
potential, have been isolated (Anjos-Afonso and Bonnet 2007; Beltrami et al. 2007; D'Ippolito et al. 
2004; Guan et al. 2006; Gupta et al. 2006; Kogler et al. 2004; Kucia et al. 2006; Ratajczak et al. 2008; 
Yoon et al. 2005). The relationship between these different stem cell populations is not understood yet. 
Whether they exist in vivo or are obtained as a consequence of in-vitro reprogramming or selection is 
not clear either. Nevertheless, obtaining cells with broad differentiation capacity from somatic tissues, 
without the need for addition of exogenous genes, may offer an alternative source of cells to study or 
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compare self-renewal, differentiations and reprogramming mechanisms, and for potential cell therapy 
and drug toxicity screening applications.
MAPC have traditionally been cultured at low density (200-300 cells/cm
2
) on tissue culture dishes, as 
it was believed that the higher-density may result in differentiation and loss of potency, as has been 
suggested for MSC (Javazon et al. 2004). Here, we explored culturing rat bone marrow derived MAPC 
as 3D cell aggregates amenable to suspension culture and scalable expansion in bioreactors. We report 
the self-assembly of MAPC into 3D cell aggregates that maintain differentiation potency over at least 
sixteen days, and their scalable expansion in 3D suspension culture, while retaining the potential for
liver differentiation application. The principles developed in this study may also be applicable for the 
scalable growth and differentiation of MSCs and other stem and progenitor cells. 
MATERIALS AND METHODS 
ESTABLISHMENT AND MAINTENANCE OF RAT MAPC LINES
Two rat MAPC lines were used in this study. The isolation of rat MAPC lines has been previously 
described (Breyer et al. 2006; Ulloa-Montoya et al. 2007). Briefly, rat MAPC lines were isolated from
the tibia and femur of 4 week old female rat (Fischer). Cells were plated on 6 well tissue culture plates 
in MAPC medium at 6 x 10
6
/well and cultured in a humidified incubator at 37?C with 5% oxygen and 
5.5% CO2. After 4 weeks of culture, hematopoeitic cells were removed using magnetic microbeads
against CD 45 and Ter 119 (Miltenyi Biotec) and the remaining cells were seeded into 96 well plates at 
5 cells/well. Cells with small size and spindle shaped morphology that appear in the wells were 
subsequently picked and screened for MAPC phenotype (expression of Oct4, Rex1 and CD31) and tri-
lineage differentiation potential (Breyer et al. 2006). The established MAPC cell lines were maintained
in MAPC medium at 37?C in a 5% oxygen and 5-6% CO2 incubator at a starting cell density of 300 
cells/cm
2
 and passaged using 0.05% (w/v) Trypsin-EDTA (5 mg/l Cellgro) every two days (Breyer et 
al. 2006).
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MAPC MEDIA
MAPC medium consisted of a basal medium that was a 60/40 (v/v) mixture of low glucose Dulbecco’s 
Modified Eagle media (DMEM) (Gibco, USA) and MCDB-201 (Sigma) supplemented with 0.026 
?g/ml ascorbic acid 3-phosphate (Sigma), linoleic acid bovine serum albumin (LA-BSA, Sigma))
(final concentrations of 10
3 ?g/ml BSA and 8.13 ?g/ml linoleic acid), insulin-transferrin-selenium
(ITS, Sigma) (final concentration 10 ?g/ml insulin, 5.5 ?g/ml transferrin, 0.005 ?g/ml sodium
selenite), 0.02 ?g/ml dexamethasone (Sigma), 4.3 ?g/ml ?-mercaptoethanol and 2% (v/v) qualified 
fetal bovine serum (Hyclone). Complete MAPC medium also contained three growth factors: human
platelet derived growth factor (PDGF-BB, R&D) (10 ng/ml), mouse epidermal growth factor (EGF, 
Sigma) (10 ng/ml) and mouse leukemia inhibitory factor (LIF) (10
3
 Units/ml) (Chemicon, ESGRO). 
All media used were also supplemented with 100 IU/ml penicillin and 100 ?g/ml streptomycin
(Gibco).
STATIC PLATE CULTURE OF MAPC AGGREGATES
MAPC aggregates were formed from single cells of MAPCs using the hanging drop method
(Kurosawa et al. 2003) or the forced aggregation method (Ng et al. 2005). Briefly, in the hanging drop 
method 300-3000 single cells were suspended in a single drop of medium hanging on an inverted 
plastic surface (Nunc) containing 60 small drops of cells and medium and each were allowed to 
agglomerate into individual aggregates. In the forced aggregation method, cells in suspension were 
placed in a well of an ultra-low attachment round bottomed 96 well plate (Corning) and centrifuged for 
4 min at 1500 rpm, to allow cells to settle to the bottom of the well. Unless otherwise specified the 
settled cells were grown in a 37?C incubator at 5% oxygen to allow for aggregates to form over time.
For static plate culture, MAPC aggregates were formed using either of the two methods. When formed
by the hanging drop method, the MAPC aggregates from day 4 were cultured in ultra-low attachment
24 well plates (Corning) with 10 aggregates/wells. Forced aggregation method aggregates were formed
and cultured for the entire culture period in 96 well plates. In both cases, MAPC medium and 5% 
oxygen conditions were used with 50% medium changes every two days. MAPC aggregates were also 
plated in differentiation conditions (MAPC medium without LIF, PDGF and EGF and 21% oxygen) 
for the same time period as maintenance cultures. 
SUSPENSION FLASK CULTURE OF MAPC AGGREGATES
Prior to suspension culture, MAPC aggregates were formed using the forced aggregation method in 
static culture for two days. Aggregates were then transferred to a 250 ml spinner flask at an initial cell 
concentration of 50,000 cells/ml and the culture was stirred at 70 rpm and kept inside a 37?C incubator 
with 5% oxygen control.
A
c
c
e
p
te
d
P
r
e
p
r
i n
t
DISSOCIATION OF MAPC AGGREGATES
To dissociate the MAPC aggregates into single cells, the aggregates were washed once with PBS and 
suspended in pre-warmed 0.05% (w/v) Trypsin-EDTA for 15-20 min in a 37?C water bath. The 
aggregates-cell suspension was pipetted a few times and subsequently incubated for an additional 5 
min in the water bath until the aggregates were dissociated into single cells, as observed under the 
microscope.
RNA ISOLATION AND QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION (RT-QPCR)
Total RNA was isolated from rMAPC cell lysates using RNAeasy microkit (Qiagen) according to 
instructions provided in the kit. cDNA was synthesized from the extracted RNA using the Superscript 
III reverse transcriptase (Invitrogen) method. The PCR reaction mix consisted of cDNA samples,
SYBR Green Mix PCR reaction buffer (Applied Biosystems) and primers (5 ?M stocks, sequences 
listed in table 1). The RT-qPCR reaction was run on a Realplex mastercycler (Eppendorf) using the 
following program: 50?C for 2 min, 95?C for 10 min, and 40 cycles at 95?C for 15 sec and 60?C for 1 
min followed by a dissociation protocol to obtain a melting curve. Transcript abundance relative to 
GAPDH was expressed as log2(Transcript expression relative to GAPDH) and calculated as ?Ct which 
is Ct(gene of interest)-Ct(GAPDH) and Transcript abundance in sample relative to day 0 was 
expressed as the log2(Transcript expression level relative to day 0) and calculated as ?Ct (day 0)- 
?Ct(day of sample). Student’s t-test with a p-value cut off of 0.05 was used to call for any significant 
difference in expression between the different samples.
INTRACELLULAR STAINING FOR OCT4 BY FLOW CYTOMETRY
Cells harvested by trypsinization were washed with and suspended in PBS with 3% (v/v) serum at 
100,000 cells per FACS tube. After fixing with 4% paraformaldehyde for 15-20 min, and blocking for 
1 hr in SAP buffer (PBS with 0.1% (w/v) saponin and 0.05% (w/v) sodium azide) supplemented with 
10% donkey serum, cells were incubated for 1 hr with 1 ?g/ml Oct3/4 antibody (Santa-Cruz, N19) or 
Goat IgG isotype control (Jackson Immunoresearch) diluted in SAP buffer before incubating with Cy5 
labeled anti-goat IgG (Jackson Immunoresearch, 1:500 in SAP buffer) for 30 min. Finally, cells were 
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washed, filtered and re-suspended in 500 ?l PBS for flow cytometry analysis using FACS Calibur 
(Becton Dickinson).
IN-VITRO DIRECTED DIFFERENTIATION FOR EVALUATING MAINTENANCE OF DIFFERENTIATION POTENCY OF 
MAPC
Neuroectodermal differentiation 
rMAPC we e cultured at 1500 cells/cm
2
 on 0.1% gelatin coated T75 flasks in neural differentiation 
medium that consisted of 50% (v/v) DMEM/F12 (Invitrogen) and 50% (v/v) neurobasal A medium
(Invitrogen) supplemented with N2 plus supplement (R&D systems), B27 (Invitrogen), 4.3 ?g/ml ?-
mercaptoethanol, 0.3 mg/ml glutamine (Invitrogen) for 2 days. On Day 2, the medium was completely
replaced with Euromed-N medium (Annovum/Euroclone) supplemented with 0.3 mg/ml glutamine, N2 
plus supplement, 4.3 ?g/ml ?-mercaptoethanol and growth factors: basic fibroblast growth factor 
(R&D, bFGF) (10 ng/ml) and EGF (Sigma) (10 ng/ml). On Day 6, cells were trypsinized and re-plated 
in 0.1% gelatin coated T25 flasks in neural differentiation medium supplemented with bFGF (10ng/ml)
and EGF (10ng/ml). Differentiations were continued for fourteen days in 5% oxygen conditions with 
media change every two days.
Endothelial differentiation 
rMAPC were cultured on fibronectin (100 ng/ml) coated 24 well plates at a cell density of 45,000 
cells/cm
2
 in MAPC media. After about 16 hr, the medium was completely replaced with endothelial 
differentiation medium whose composition was the same as MAPC medium except that the three 
growth factors were absent, dexamethasone was at 0.4 ?g/ml, and that 10 ng/ml recombinant human
VEGF (R&D) was added. Differentiations were continued for twenty days in 21% oxygen conditions 
with 50% media change every two days.
Hepatocyte differentiation 
rMAPC were cultured on matrigel (2%, BD) coated wells of a 24 well plate at a starting cell density of 
50,000 cells/cm
2
 in MAPC medium until a confluence of 80-90% is reached. Subsequently, the 
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expansion medium was completely replaced with differentiation basal medium whose composition was 
the same as MAPC medium except that ITS and LA-BSA were at 25% of the amount in MAPC 
medium, dexamethasone was at 0.4 ?g/ml and the three protein factors and serum were absent. 
Furthermore, additional protein factors were added as described below. The cytokines and growth 
factor supplements were added as follows: (i) Day 0: Activin A at 100 ng/ml and Wnt3a at 50 ng/ml
(ii) Day 6: bFGF at 10 ng/ml and BMP4 at 50 ng/ml (iii) Day 10: FGF8b at 25 ng/ml, aFGF at 50 
ng/ml and FGF4 at 10 ng/ml (iv) Day 14: HGF at 20 ng/ml and Follistatin at 100 ng/ml.
Differentiations were carried out for twenty days in 21% oxygen conditions with 50% media change, 
corresponding to the differentiation stage, every two days. On days 0, 6, 10, and 14, complete medium
was replaced with fresh medium with supplements for the ensuing differentiation stage. 
TIME LAPSE MICROSCOPY
MAPCs were seeded at 1000 cells/well in ultra-low attachment round bottom 96 well plates (Corning). 
The initial aggregation of the cells was observed by microscope (Leica) located in an incubation 
system of 37?C, 5% CO2, and 5% or 21% O2 for 48 hours. Images of cells undergoing aggregation 
were taken every 4 min over 48 hr.  The size of aggregates was determined from an average of three or 
more wells each containing a single aggregate. 
TRANSMISSION ELECTRON MICROSCOPY
Cells aggregates were washed thrice with 0.1 M cacodylate buffer and fixed in 2.5% glutaraldehyde 
and 0.1 M sodium cacodylate buffer (pH 7.2) for 40 min. After post-fixation in 1% osmium tetroxide 
and 0.1 M of cacodylate buffer, the samples were dehydrated in graded series of ethanol folloed by 
propylene oxide treatment, and embedded in epoxy resin. Ultrathin sections were cut, stained with 
uranyl acetate and lead citrate, and examined using a JEOL 1200 EXII electron microscope at the 
Characterization facility at University of Minnesota.
E-CADHERIN STAINING
Cells aggregates were fixed in 4% paraformaldehyde for 30 min and washed with PBS. The samples
were incubated in 5% sucrose in PBS overnight and supercooled with isopentane before freezing in 
OCT and obtaining sections. H2O2 was used to inhibit endogenous peroxidase and incubated with fetal 
bovine serum (FBS) to reduce non-specific binding. Cells were then incubated with anti-E-cadherin 
(BD) antibody or with isotype-matched negative control antibodies (mouse IgG2a) and then 
subsequently visualized using EnVision-Peroxidase with DAB substrate (Dako). 
CELL VIABILITY STAINING
The “live/dead viability/cytotoxicity kit” (Invitrogen) was used to stain cells in the aggregates with 
calcein and ethidium. Component B was added first to DPBS (1:1000) and then component A was 
added to DPBS with component B (1:2000). Cells were incubated with the staining solution for 15-30 
min at 37?C. Cells were washed once with PBS and observed under inverted fluorescent microscope
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(Axiovert 200, Zeiss). Live and dead cells appear as green and red respectively. Validation of the 
protocol to detect dead cells was confirmed with the red stain observed in cells in aggregates that were 
treated with 0.1% (w/v) saponin (to induce permeabilization based cell death) for 30 min prior to the 
staining protocol. 
CELL CYCLE ANALYSIS
Cells were fixed in 80% ethanol and stored at -20°C. Fixed cells were washed twice with PBS and then 
stained in PBS with 50µg/ml propidium iodide and 0.1 mg/ml RNAse overnight at 4°C. After washing 
cells were filtered and re-suspended in 500µl PBS for flow cytometry analysis using FACS Calibur. 
RESULTS
MAPC self-assemble into cell aggregates
We evaluated aggregate formation from single suspensions of MAPCs using two methods known as 
the hanging drop and the forced aggregation methods. rMAPC were inoculated at a starting cell 
concentration ranging from 3000-30,000 cells/ml (or 300 to 3000 cells per well or per drop) and single 
aggregate from each drop or well was readily formed. Aggregates were formed in complete MAPC 
medium or MAPC medium without LIF, PDGF and EGF (differentiation medium) in 5% or 21% 
oxygen. For all studies, two rat MAPC lines were tested at least in triplicates. Aggregates formed in 
complete MAPC medium with 5% oxygen, on day 4, expressed Oct4, Rex1, CD31 and HNF3b 
transcripts at levels comparable to the parent MAPC-line cultured on 2D surface (5% oxygen), but not 
Afp, a gene we have shown to be rapidly up-regulated when MAPC differentiate spontaneously (Figure 
1a). In addition, Oct4 protein expression was maintained in these aggregates as shown by flow 
cytometry (Figure 1b).  In contrast, aggregates formed in MAPC medium at 21% oxygen, were 
differentiating, as they expressed a 32 fold more Afp transcript (Figure 1c) and the fraction of cells 
expressing Oct4 protein decreased by about 50% (Figure 1d). Formation of aggregates in MAPC 
medium without LIF, PDGF and EGF even with a 5% oxygen resulted in a 21 fold decrease in Oct4
transcript (Figure 1c) with only about 4% of the cells expressing Oct4 protein (Figure 1d). Thus, both 
high ambient oxygen concentrations and removal of LIF, PDGF and EGF negatively affected the Oct4
expression during aggregate formation, and resulted in differentiation.  Cells in MAPC aggregates 
formed under 5% O2 in complete MAPC medium could also be trypsinized to single cell suspensions 
and re-cultivated on 2D surface exhibiting typical MAPC proliferation profiles and phenotype 
(Supplementary Figure 3).
Characterization of the MAPC aggregates and their formation
Four days after cell seeding, the MAPC aggregates had barely distinguishable cell-cell boundaries 
(Figure 2a).  Time-lapse microscopy was used to visualize the process of aggregate formation over a 
period of 48 hr. After the centrifugal settling to the bottom of a well, single cells clustered together to 
an average size of 540 ?m. Subsequent compaction led to the cell aggregates of about 250 ?m in size. 
The aggregate then increased in size to about 460 ?m by 48 hr after the initial agglomeration (Figure 
2b). 10 aggregates were dissociated by trypsinization every day for cell counting. The average number
of cells in ach aggregate increased from 1000 to 17,758 cells per aggregate (668 ? 19 ?m, mean and
SD of ten aggregates) in four days (Figure 2c).
The population doubling time during the four days of formation was about 23 hr, slower than that seen 
when cultivated on a 2D surface (12-14 hr). The doubling time between Day 1 to 3 is approximately 12 
hr. Between Day 3 and Day 4, a slow down in cell growth is observed (Figure 2c). Cell cycle analysis 
done by flow cytometry indicated that a larger fraction (60%) of MAPC in aggregates (Day 4) were in 
G0/G1, in comparison to 2D surface culture (40%) (Supplementary Figure 4). TEM analysis of the 
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aggregates showed tightly packed cells with high nucleus to cytoplasm ratio, a characteristic of 
MAPCs. Tight junctions were seen at cell-cell boundaries (Figure 2d). Immunohistochemistry
demonstrated that MAPC in aggregates expressed the cell membrane associated adhesion protein E-
cadherin (Figure 2e).
MAPC aggregates retain differentiation potential in culture 
We next examined whether MAPC aggregates could be maintained in culture for an extended periods 
of time without losing their characteristic phenotype. MAPC aggregates were allowed to form for four 
days and were subsequently kept for another sixteen days in complete MAPC culture medium or 
MAPC medium without LIF, PDGF and EGF with 50% medium change every two days. RT-qPCR for 
Oct4 and Afp transcript expression was used to evaluate the undifferentiated status of culture. MAPC 
aggregates maintained the level of Oct4 transcript without increase in Afp transcript level. However, 
for MAPC aggregates cultured in MAPC medium without LIF, PDGF and EGF (and with 21% 
oxygen), expression of Oct4 transcript decreased and the expression of Afp transcript progressively 
increased with time (Figure 3a, 3b). During the sixteen days of culture in complete MAPC culture 
medium, cell proliferation occurred, as noted by the increase of the aggregates size or budding off of 
small groups of cells from the single MAPC aggregate to form smaller aggregate (Supplementary
Figure 5).
After sixteen days in culture, the MAPC aggregates were dissociated into single cells by trypsinization 
and the expression of Oct4 protein was evaluated by flow cytometry (Figure 3c, 3d). The fraction of 
cells that continued to express Oct4 protein at the end of the sixteen-day culture (79% for one MAPC 
line and 78% for the other MAPC line) was similar to 2D monolayer cultures and MAPC aggregates 
on Day 0 (Figure 1b). These cells were re-expanded and after two passages of expansion in 2D surface 
at low cell density, aggregate-derived cells were used for directed differentiation towards endothelial, 
hepatic and neural progenitor lineages and the differentiations were compared to that of MAPC 
maintained for the whole period at low cell density in 2D surface culture. As can be seen in Figure 4, 
no significant differences in differentiation could be detected (student’s t-test, with a p value cutoff of
0.05). During neural differentiation, similar increases in levels of expression of Sox2, Pax6 and Nestin
transcripts were observed in both cells cultured as aggregates for sixteen days followed by 2D surface 
culture, as cells maintained in 2D surface culture for the whole time period (Figure 4a). Similar results 
were observed in the endothelial differentiation as demonstrated by the increased expression of Flk-1,
Ve-Cadherin, vWF, Enos transcripts (Figure 4b), and in the hepatocyte lineage differentiation, shown 
by the increase in expression of Afp, Albumin, Aat and Tat transcripts (Figure 4c). Thus, MAPC can be 
cultured as aggregates for at least sixteen days with differentiation potential for all three lineages. 
Expansion of MAPC as aggregates in suspension culture
We also explored if MAPC can be expanded as aggregates in suspension culture. The cultures were 
repeated three times with one MAPC cell line (Figure 5) and twice with another MAPC line 
(Supplementary Figure 6). MAPC aggregates were formed under static culture conditions for two days 
and then seeded into a 250 ml spinner flask with a 100 ml working volume.  During the first two days 
of static culture (day -2 to day 0) cell concentration grew from 10
4
 to 5 x 10
4
 cells/ml. From day 0 to 
day 2 of suspension culture, an additional six-fold increase in cell number was seen.  On day 2 of 
suspension culture, cell aggregates were harvested and the cell concentration in the flask was reduced 
to 50% and 50 ml of fresh medium was added. At the end of six days of culture, a final cell 
concentration of 7 x 10
5
 cells/ml, equivalent to 70 fold expansion, was obtained for rMAPC-1 (Figure 
5a).  Similar cell concentration was obtained on Day 4 of spinner expansion culture of the other rat 
MAPC line as well (Supplementary Figure 6a). 
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Staining with the LIVE/DEAD cytotoxicty kit (Molecluar Probes) demonstrated that the cells within 
the aggregates (day 4) retained high viability (Figure 5b).  The transcript levels of key MAPC genes 
such as Oct4, Rex1, CD31, Sall4 and differentiation marker Afp of Day -2 (cells from 2D maintenance
culture), Day 0 (cells after 48 h aggregation in wells) and Day 2 and 4 (aggregates in spinner cultures) 
were assessed by RT-qPCR. No differences in Oct4, Rex1, CD31 and Sall4 transcripts could be 
detected, and no increase in AFP expression was observed (Figure 5c, Supplementary Figure 6b). In 
addition, the expression of Oct4 protein was also evaluated by flow cytometry. The fraction of cells 
that continued to express Oct4 protein at the end of spinner flask culture (day 4, 77% for one MAPC 
line and 74% for the other MAPC line) and the control 2D surface culture (day4, 79%) was similar
(Figure 5d, Supplementary Figure 6c). Thus, the cells in stirred suspension culture could be expanded 
without obvious signs of differentiation. 
To evaluate whether MAPC aggregate cultivated in spinner continued to have similar differentiation
potential, Day 0, 2 and 4 aggregates were subjected to hepatocyte differentiation as aggregates in static 
culture on 24 well ultra-low attachment plates using a protocol previously developed by our lab 
(manuscript submitted). Differentiation towards the hepatocyte lineage was chosen because in vitro
drug testing applications require large quantity of hepatocytes. We evaluated the extent of up-
regulation of hepatocyte-specific transcripts by RT-qPCR at the end of twenty days of differentiation 
of cell aggregates collected at different points of spinner culture, over the expression levels in the 
starting cell aggregates, in each case. We demonstrate that the MAPC aggregates (from Day 0, 2 and 4) 
were differentiated to ‘hepatocyte-like’ cells as shown by the up-regulation of hepatocyte specific 
transcripts Afp, Albumin, Aat and Tat (Figure 5e). The level of up-regulation of these genes was similar
for all starting cell populations. In addition, differentiated cells from each of the differentiations also 
secreted albumin at 0.7-0.8 pg/cell/day or about 10% of the level secreted by adult rat hepatocytes, and 
urea was secreted at 4-7 ?g/day. Thus, the cells expanded in the spinner culture can also be used for 
generating large numbers of ‘hepatocyte-like’ cells. 
DISCUSSION
Stem cells offer great potential for regenerating and replacing dysfunctional tissues, and as tools for 
research on normal differentiation processes, models of disease, and for drug toxicity testing. Because 
of their importance in regenerative medicine and research, there is an increasing interest in the 
development of robust bioprocesses for generating large quantities of stem cells and their differentiated 
derivatives. Several bioreactor designs have been tested for cultivation of different stem cell types 
(reviewed extensively in (Kehoe et al. 2009; King and Miller 2007; Kirouac and Zandstra 2008).) 
Among the different bioreactors, stirred tank based designs have been most widely used for the 
cultivation of mammalian cells because of the ease in maintaining homogenous environment with 
online process monitoring and control. Furthermore, extensive experience and knowledge on their 
design and operation has accumulated in the past that will be useful in the scale up of stem cell 
bioprocesses.
MAPC’s capability of extensive self-renewal and multi-lineage differentiation ability to lineages of
cell three germ layers (Breyer et al. 2006; Luttun et al. 2006; Schwartz et al. 2002; Ulloa-Montoya et 
al. 2007) makes them an excellent model for study of developmental processes. Subsequent to the 
initial isolation of MAPCs, we have further optimized a robust isolation procedure to obtain multiple
rat MAPC lines, from fetal and adult bone marrow, with very similar phenotype and differentiation 
capabilities (Subramanian et al.). However, the need for low-density maintenance of MAPCs 
constitutes a technical hurdle for potential clinical translation. We recently found that MAPCs can be 
cultured at higher cell densities (1000 cells/cm
2
, with a cell concentration of ~10
5
/ml) without change 
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in multi-lineage differentiation capability when cultivated in 2D under 5% oxygen (Park et.al, 
manuscript submitted). This prompted us to evaluate the possibility of growing MAPC as aggregates 
for suspension culture in a stirred tank. We adopted the hanging drop (Kurosawa et al. 2003) and 
forced aggregation (Ng et al. 2005) methods because of their ease of use and the high-efficiency of 
aggregate formation. Both methods gave relatively uniform sizes of aggregates and allowed cells to 
continue to proliferate during aggregate formation (Kelm et al. 2003; Kurosawa 2007). This capability 
of growing as aggregates has been seen in multiple rat MAPC lines from independent isolations.  The 
aggregates appeared tightly packed, expressing cell membrane associated E-Cadherin. Fibronectin, an 
extracellula  matrix protein, was expressed at higher transcript levels in 3D aggregates than in 2D 
MAPCs cultivated on fibronectin coated dishes (supplementary Figure 2a). In addition, the MAPCs, 
cultivated on plates coated with conditioned medium from the aggregate (3D) culture, expanded to 
similar cell numbers as those cultivated on fibronectin coated plates. In contrast, a significantly lower 
cell number was obtained on plates coated with conditioned medium from 2D surface culture or on 
plates without any coating (supplementary Figure 2b). This enhanced cell-cell and cell-matrix
interactions seen in 3D aggregates may also help in better recapitulating the native microenvironment
for applications in the study of development and morphogenesis, drug screening, stem cell 
differentiation, tissue engineering and tumor biology, in addition to their applicability in scalable 
suspension cultures. As an illustration, we observe improved efficiency and maturation of hepatocyte 
differentiation from 3D MAPC aggregates as compared to 2D MAPC surface culture (manuscript in 
preparation).
MAPC express Oct4 protein in the nucleus (Breyer et al. 2006), a transcription factor expressed in 
morula, inner cell mass (ICM), epiblast and hypoblast, as well as in embryonic stem cells (ESC) and 
male germline stem cells (Guan et al. 2006; Niwa 2007; Ralston and Rossant 2005). Oct4 is known to 
crucial for the pluripotent nature of cells in the ICM, epiblast and ESC. In addition to MAPC, other 
bone marrow derived stem or progenitor cells have also been reported to express Oct4 mRNA/protein
(D'Ippolito et al. 2004; Kucia et al. 2006; Pochampally et al. 2004). When cultured without LIF, 
MAPC rapidly lose Oct4 and begin to show signs of differentiation with rapid up-regulation of Afp,
expressed in the visceral endoderm (manuscript in preparation). In addition to Oct4, MAPC also 
express other ESC transcription factors including Sall4 and Rex1 as well as transcription factors of 
primitive endoderm/visceral endoderm/definitive endoderm such as Hnf3b, Gata4, Gata6, Sox7, and 
Sox17 (Ulloa-Montoya et al. 2007). Aggregates formed in complete MAPC medium and 5% oxygen 
and maintained in either static or suspension culture expressed Oct4, Sall4, Rex1, CD31, GATA6, 
GATA4, Sox7, Sox17 and Hnf3b transcripts at levels expressed in MAPC grown in 2D, but no Afp
transcripts. MAPC aggregates also expressed similar levels of Oct4 protein that in 2D. Other 
pluripotent stem cells including mouse ESCs have also been cultured in suspension as undifferentiated 
aggregates in a medium supplemented with LIF (Cormier et al. 2006). For ESC, withdrawal of LIF 
from the medium results in differentiation of ESC into embryoid bodies (EBs) (Kurosawa 2007; 
Kurosawa et al. 2003). In addition to the requirement of LIF (and EGF, PDGF), we found 5% oxygen 
is favorable for maintaining and expanding undifferentiated MAPC as aggregates or in 2D surface 
culture. This is consistent with the findings that culturing hematopoietic stem and progenitor cells 
(HSCs) at low oxygen tension (1-5%) maintained the earliest progenitor cells, while increase in 
oxygen tension resulted in differentiation into more mature cell types (Hevehan et al. 2000; Mostafa et 
al. 2000). Likewise, low oxygen tension facilitated the expansion and maintenance of stem cell genes 
in MSCs as well (D'Ippolito et al. 2006; Grayson et al. 2006).
While the phenotype of MAPC in aggregates was mostly similar to that of MAPC in 2D surface 
culture, we noticed increased expression of Cxcr4, Flk1 and Sox2 in the aggregate compared with 
MAPCs harvested from 2D surface culture. Cxcr4 is a receptor responsible for stem cell homing to 
stromal derived-factor 1 (SDF1) and is also up-regulated when human MSC are cultured as 3D 
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aggregates (Potapova et al. 2008). We speculate that up-regulation of Flk1 may be due to hypoxic 
responsiveness of the cells within the aggregate, as has been observed in other systems (Purpura et al. 
2008). It is interesting to see a modest up-regulation of Sox2, a transcription factor found in the ICM, 
epiblast and ESC as well as in NSC, in the MAPC aggregates (Rizzino 2009). In N2/B27 medium,
MAPC express transcripts specific for neuroectoderm progenitors including Sox2 and Pax6 (Ulloa-
Montoya et al. 2007). However, as no increase in expression of Pax6 was observed in the aggregates, 
an early commitment to the neuroectoderm lineage is unlikely. Upon cell dissociation of the aggregates 
and replating in 2D surface culture, the expression of Cxcr4, Flk1 and Sox2 transcripts returned to 
levels seen before 3D aggregate formation.
Importantly, to demonstrate that MAPCs in aggregates retained their potency, cells cultured as 
aggregates for sixteen days were tested for their ability to differentiate to the neuroectoderm,
endothelial and hepatic lineage (Luttun et al. 2006; Ulloa-Montoya et al. 2007). Consistent with our 
finding that the phenotype of MAPC was unchanged when cultured in aggregates, the induction of 
lineage-specific transcripts was similar for cells dissociated from day 16-aggregate and the cells 
maintained in low-density 2D surface culture. Thus, we demonstrated that the cells in the aggregate 
still retained multi-lineage differentiation potential. However, as the cells derived from the aggregate 
were expanded for two passages in 2D to obtain enough cells for differentiation, the possibility exists 
that the differentiation seen is the result of a subfraction of cells that retained this ability and outgrew 
other cells that had lost differentiation potential. We therefore also assessed if differentiation to the 
hepatocyte-lineage could be obtained from the MAPC aggregates themselves, without replating onto 
2D surface cultures. As the aggregates collected at different points of spinner culture (day 0, 2 and 4) 
themselves could be differentiated to hepatocyte-like cells with similar levels of induction of 
hepatocyte specific transcripts as well as albumin and urea secretion rates, this strongly suggests that 
there was no progressive loss of potency of MAPCs during the four days of spinner culture as 
aggregates.
The culture platform described in this report allows for a 70-fold cell expansion of rat MAPCs (two 
MAPC lines) that retain the expression of MAPC markers at both mRNA and protein levels. 
Furthermore, this spinner expanded MAPC aggregates are capable of differentiating into ‘hepatocyte-
like’ cells. Stem cell derived ‘hepatocyte-like’ cells have applications in drug bioavailability and 
hepatoxicity evaluation studies, in bioartificial liver devices, and in cell therapies for a wide variety of 
liver disorders.  Many of those applications require a large quantity of cells. Aggregate based 
suspension culture will facilitate cell expansion as well as mass differentiation of stem cells to 
hepatocytes.   Extension of this platform for human stem cell cultivation will greatly facilitate potential 
clinical applications of stem cell derived hepatocytes.  We envisage further studies of this and other 
similar culture platforms to lay the foundation of stem cell culture processes in the near future. 
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Figure 1. Aggregates retain MAPC phenotype. (a) Transcript level of pluripotency, primitive
endoderm and differentiation markers of surface cultured (?/?) and aggregates (Day 4, ?/?) of MAPC 
(Data of 2 lines are shown for each). (b) Flow cytometric measurement of Oct4 protein in aggregates 
and surface cultured MAPC (negative isotype control and Oct4 antibody treated samples are shown in 
both cases) (c) Transcript level of Oct4 (?) and AFP (?), and (d) Flow cytometric measurement of 
Oct4 in aggregates formed in 21% oxygen or in differentiation inducing conditions (negative isotype 
control and Oct4 antibody treated samples are shown in red and blue respectively). 
Figure 2. Characterization of MAPC aggregates a) Morphology of MAPC aggregates (Day 4), 
(scale bar 200 ?m) (b) Change in aggregate size during the first 48 hr of aggregate formation (c) Cell 
proliferation during aggregate formation e) TEM section of MAPC aggregate (d) E-cadherin staining. 
Figure 3. Static Culture of MAPC aggregates: Change of (a) Oct4 and (b) AFP transcript levels in 
16 day culture of (?/?) aggregate culture; (?/?) aggregate in differentiation medium. Black and white 
symbols represent the different MAPC lines (c), (d) Flow cytometric measurement of Oct4 in MAPC 
aggregates on Day 16 in the two rat MAPC lines (negative isotype control and Oct4 antibody treated 
samples are shown in red and blue respectively) 
Figure 4. Directed differentiation of aggregate derived MAPC (Day 16) (a) Transcript levels of 
neural progenitor markers Sox2, Nestin, Pax6 in neural differentiation (b) Transcript levels of 
endothelial markers Flk-1, Ve-Cadherin, vWF, enos in endothelial differentiation (c) Transcript 
expression of hepatocyte markers AFP, Albumin, AAT, TAT in hepatocyte differentiation (?/?): surface 
culture (?/?): day 16 aggregate derived cells (Data from two different cell lines are shown for each, 
mean of n=3 differentiations)
Figure 5. Expansion of MAPC cell aggregates in spinner flasks (a) Cell proliferation profile (b) 
Vital stain of MAPC aggregates (Day 4) (c) Transcript level of MAPC markers (?) Oct4;(?) Rex1;(?)?
CD31;(?) Sall4;(?) AFP (average of three spinner flask runs) (d) Flow cytometric measurement of
Oct4 in MAPC aggregates at the end of spinner culture (day 4) and in control 2D culture (day4) 
(negative isotype control and Oct4 antibody treated samples are shown in red and blue respectively) (e) 
Transcript level of hepatocyte markers in hepatocyte differentiation conditions in static culture starting 
from (?): Day 0;(?): Day 2; (?): Day 4 cells of spinner expansion culture.
Supplementary Figures 
S1. Transcript level of MAPC/primitive endoderm markers (?): surface culture (?): MAPC cell 
aggregate in static culture and (?): MAPC cell aggregate in suspension culture
S2.  a) Transcript level of fibronectin in surface culture (2D MAPCs), cell aggregate (3D MAPCs) and 
rat universal mRNA b) Growth of MAPCs on fibronectin or aggregate culture conditioned medium
(3D CM) or surface culture conditioned medium (2D CM) coated plates or without coating 
S3.  Replating of MAPC aggregates a) Transcript level of pluripotency and differentiation markers in 
surface cultured (?), aggregates (Day 4, ?) and replated surface culture of aggregate derived cells 
(passage 2, ?) of MAPCs b) Morphology of surface cultured MAPCs c) Morphology of replated 
surface culture of aggregate derived cells 
S4.  Cell cycle distribution in surface culture of MAPCs (?) and MAPC aggregates (Day 4, ?) in 
maintenance medium, surface culture of MAPCs in differentiation medium (DM, ?)
S5.  Morphology of MAPC aggregates on day 10 of static culture to demonstrate the beginning of 
budding of a small group of cells from each cell aggregate 
S6. Expansion of MAPC aggregates in spinner flask for another rat MAPC line (a) Cell proliferation
profile for two expansion runs (b) Transcript level of MAPC markers on MAPC aggregates (Day 0, ? ; 
Day 4 Run 1, ? ; Day 4 Run 2, ?) (c) Flow cytometric measurement of Oct4 in MAPC aggregates on 
Day 4 (negative isotype control and Oct4 antibody treated samples are shown in red and blue 
respectively)
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TABLE 1: LIST OF PRIMERS FOR PCR 
Cell Lineage Gene Forward Primer Reverse Primer 
Housekeeping Gapdh AAGGGCTCATGACCACAGTC GGATGCAGGCATGATGTTCT
Pluripotency
/MAPC Oct4 CTGTAACCGGCGCCAGAA TGCATGGGAGAGCCCAGA
Rex1 AAAGCTTTTACAGAGAGCTCGAAACTA GTGCGCAAGTTGAAATCCAGT
Sall4 AGAACTTCTCGTCTGCCAGTG CTCTATGGCCAGCTTCCTTC
CD31 GGACTGGCCCTGTCACGTT TTGTTCATGGTGCCAAAACACT
HNF3b GCAGAACTCCATCCGTCATT TCGAACATGTTGCCAGAGTC
GATA4 CTGTGCCAACTGCCAGACTA AGATTCTTGGGCTTCCGTTT
GATA6 GTCTGGATGGAGCCACAGTT ATCATCACCACCCGACCTAC
SOX7 CAAGGATGAGAGGAAACGTC CTCTGCCTCATCCACATAGG
SOX17 GCCAAAGACGAACGCAAGCGG TCATGCGCTTCACCTGCTTG
Hepatic lineage AFP ACCTGACAGGGAAGATGGTG GCAGTGGTTGATACCGGAGT
Albumin TCTGCACACTCCCAGACAAG AGTCACCCATCACCGTCTTC
AAT CAAACAAGGTCAGCCATTCTC CAGCATCATTGTTGAAGACCC
TAT GGAAGCTAAGGATGTCATTCTG GACCTCAATTCCCATAGACTC
Endothelium Flk-1 CCAAGCTCAGCACACAAAAA CCAACCACTCTGGGAACTGT
Ve-
Cadherin GGCCAACGAATTGGATTCTA GTTTACTGGCACCACGTCCT
vWF CCCACCGGATGGCTAGGTATT GAGGCGGATCTGTTTGAGGTT
enos TCCAGTAACACAGACAGTGCA CAGGAAGTAAGTGAGAGC
Neuroectoderm Sox2 GGCCAACGAATTGGATTCTA GTTTACTGGCACCACGTCCT
Pax6 GTCCATCTTTGCTTGGGAAA TAGCCAGGTTGCGAAGAACT
Nestin CCCCAGAAACAGAAGAAGATGAG CATGGGCATCTGTCAGGATTG
